How approved products differ, what oral options mean, and why treatment choice is individual.
What is the difference between semaglutide and tirzepatide?
Semaglutide acts at the GLP-1 receptor, while tirzepatide acts at both GIP and GLP-1 receptors. They have different products, indications, dose schedules, warnings, results, and coverage. The better choice depends on the individual.
What is the difference between Ozempic and Wegovy?
Both contain semaglutide, but they are separate FDA-approved products with different indications, presentations, and dosing instructions. Ozempic is approved for type 2 diabetes and certain related risk reductions; Wegovy has weight-management and certain cardiovascular indications.
What is the difference between Mounjaro and Zepbound?
Both contain tirzepatide, but they are separate products with different FDA-approved indications. Mounjaro is approved for type 2 diabetes; Zepbound is approved for chronic weight management and, in certain adults with obesity, moderate-to-severe obstructive sleep apnea.
Is tirzepatide a GLP-1?
Tirzepatide is commonly grouped into the GLP-1 conversation, but technically it is a dual GIP and GLP-1 receptor agonist. That distinction matters when explaining labels, dosing, and study results.
Is there an FDA-approved GLP-1 pill for weight loss?
Current product approvals must be checked against the FDA database on the review date. The clinic should distinguish any approved oral product from investigational or compounded formulations and must not claim to offer a product until availability is verified.
How is an oral GLP-1 different from a weekly injection?
Oral and injectable products can contain different forms, doses, schedules, and administration instructions. Do not convert doses or switch forms without a prescriber’s instructions.
What is orforglipron?
Orforglipron is an oral investigational or approved product only according to its current FDA status and label. It is not semaglutide or tirzepatide, should not be treated as interchangeable with them, and should not be promoted before current approval and availability are verified.
Is retatrutide FDA approved?
Do not describe retatrutide as FDA approved unless the FDA approval database confirms that status on the publication date. FDA has warned that retatrutide has not been found safe and effective for any condition and must not be promoted as a compounded or research product.
Can I take two GLP-1 medications together?
Generally, approved weight-management labels say not to use a product with another medicine containing the same ingredient or another GLP-1 receptor agonist. Combining medicines is not established as safe simply because each was prescribed separately.
Which GLP-1 medication causes the most weight loss?
Trial averages differ by drug, dose, population, diabetes status, study length, and analysis. A higher average in one trial does not predict an individual result or make that product the safest choice. Compare current labels and evidence with a qualified prescriber.